BIBLIOGRAFIA
[1] Coates, A.; Hu, Y.; Bax, R.; Page, C., Nat. Rev. Drug Discovery 2002, 1, 895–910
[2] Fischbach, M. A.; Walsh, C. T. Antibiotics for Emerging Pathogens.
Science 2009, 325, 1089–1093.
[3] Dixon, S.; Ziebart, K. T.; He, Z.; Jeddeloh, M.; Yoo, C. L.; Wang, X.;
Lehman, A.; Lam, K. S.; Toney, M. D.; Kurth, M. J.
Aminodeoxychorismate synthase inhibitors from one-bead one-compound combinatorial libraries: “staged” inhibitor design. J. Med. Chem. 2006, 49, 7413–7426.
[4] Morphy, R.; Kay, C.; Rankovic, Z. From magic bullets to designed multiple ligands. Drug Discovery Today 2004, 9, 641–651.
[5] Barkan, D.; Liu, Z.; Sacchettini, J. C.; Glickman, M. S. Mycolic Acid Cyclopropanation is Essential for Viability, Drug Resistance, and Cell Wall Integrity of Mycobacterium tuberculosis. Chem. Biol. 2009, 16, 499–
509.
[6] Kristin T. Ziebart, Seth M. Dixon, Belem Avila, Mahomed H. El-Badri, Kathtryn G. Guggenheim, Mark J. Kurth, and Michael D.Toney, J. Med.
Chem. 2010, 53, 3718–3729
[7] Sternson, S. M.; Wong, J. C.; Grozinger, C. M.; Schreiber, S. L. Synthesis of 7200 small molecules based on a substructural analysis of the histone deacetylase inhibitors trichostatin and trapoxin. Org. Lett. 2001, 3, 4239–
4242.
[8] Parsons, J. F.; Jensen, P. Y.; Pachicara, A. S.; Howard, A. J.; Einsenstein, E.; Ladner, J. E. Structure of Escherichia coli aminodeoxychorismate synthase: architectural conservation and diversity in chorismate-utilizing enzymes. Biochemistry 2002, 41, 2198-2208.
[9] Spraggon, G.; Kim, C.; Nguyen-Huu, X.; Yee, M. C.; Yanofsky, C.; Mills, S. E. The structures of anthranilate synthase of Serratia marcescens crystallized in the presence of (i) its substrates, chorismate and glutamine, and a product, glutamate, and (ii) its endproduct inhibitor, L-tryptophan.
Proc. Natl. Acad. Sci. U. S. A. 2001, 98, 6021-6026.
[10] Morollo, A. A.; Eck, M. J. Structure of the cooperative allosteric anthranilate synthase from Salmonella typhimurium. Nat. Struct. Biol.
2001, 8, 243-247.
[11] Ze He, Kimberly D. Stigers Lavoie, Paul A. Bartlett, and Michael D.
Toney, J. Am. Chem. Soc. 2004, 126, 2378-2385.
[12] Roberts, C. W.; Roberts, F.; Lyons, R. E.; Kirisits, M. J.; Mui, E. J.;
Finnerty, J.; Johnson, J. J.; Ferguson, D. J.; Coggins, J. R.; Krell, T.;
Coombs, G. H.; Milhous, W. K.; Kyle, D. E.; Tzipori, S.; Barnwell, J.;
Dame, J. B.; Carlton, J.; McLeod, R. J. Infect. Dis. 2002, 185 (Suppl. 1), S25-36.
[13] Shah, J. Curr. Opin. Plant Biol. 2003, 6, 365-371.
[14] Calfee, M. W.; Coleman, J. P.; Pesci, E. C. Proc. Natl. Acad. Sci. U. S. A.
2001, 98, 11633-7.
[15] Anderson, K. S.; Kati, W. M.; Ye, Q. Z.; Liu, J.; Walsh, C. T.; Benesi, A.
J.; Johnson, K. A. J. Am. Chem. Soc. 1991, 113, 3198-3200.
[16] Walsh, C. T.; Liu, J.; Rusnak, F.; Sakaitani, M. Chem. Rev. 1990, 90, 1105-1129.
[17] Kozlowski, M. C.; Tom, N. J.; Seto, C.T.; Sefler, A. M.; Bartlett, P. A. J.
Am. Chem. Soc. 1995, 117, 2128-2140.
[18] Walsch, C. T.; Erion, M. D.; Walts, A. E.; Delany, J. J., III; Berchtold, G.
A. Biochemistry 1987, 26, 4734-45.
[19] Stigers, K. D.; Mar Tang, R.; Barlett, P. A. J. Org. Chem. 1999, 64, 8409- 8410.
[20] Bornemann, S.; Ramjee, M. K.; Balasubramanian, S.; Abell, C.; Coggins, J. R.; Lowe, D. J.; Thorneley, R. N. J. Biol. Chem. 1995, 270, 22811-5.
[21] Davies, G. M.; Barrett-Bee, K. J.; Jude, D. A.; Lehan, M.; Nichols, W.
W.;Pinder, P. E.; Thain, J. L.; Watkins, W. J.; Wilson, R. G. Antimicrob.
Agents Chemother. 1994, 38, 403-6.
[22] Easson, M. A. M.; Rees, D. C. Combinatorial chemistry: tools for the medicinal chemist. Med. Chem. (Wiley) 2002, 359-381.
[23] Lee, A.; Breitenbucher, J. G. The impact of combinatorial chemistry on drug discovery. Curr. Opin. Drug DiscoVery DeV. 2003, 6 (4), 494-508.
[24] Lam, K. S.; Lehman, A. L.; Song, A.; Doan, N.; Enstrom, A. M.;
Maxwell, J.; Liu, R. Synthesis and screening of “one-bead onecompound”
combinatorial peptide libraries. Methods Enzymol. 2003, 369, 298-322.
[25] Alluri, P. G.; Reddy, M. M.; Bachhawat-Sikder, K.; Olivos, H. J.;
Kodadek, T. Isolation of protein ligands from large peptoid libraries. J.
Am. Chem. Soc. 2003, 125 (46), 13995-14004.
[26] Hu, Y.; Helm, J. S.; Chen, L.; Ginsberg, C.; Gross, B.; Kraybill, B.;
Tiyanont, K.; Fang, X.; Wu, T.; Walker, S. Identification of selective inhibitors for the glycosyltransferase MurG via high-throughput screening.
Chem. Biol. 2004, 11 (5), 703-711.
[27] Wang, X.; Zhang, J.; Song, A.; Lebrilla, C. B.; Lam, K. S. Encoding method for OBOC small molecule libraries using a biphasic approach for ladder-synthesis of coding tags. J. Am. Chem. Soc. 2004, 126 (18), 5740- 5749.
[28] Liu, R.; Marik, J.; Lam, K. S. A novel peptide-based encoding system for
“one-bead one-compound” peptidomimetic and small molecule combinatorial libraries. J. Am. Chem. Soc. 2002, 124 (26), 7678-7680.
[29] Dixon, S. M.; Li, P.; Liu R.; Wolosker, H.; Lam, K. S.; Kurth, M. J.;
Toney, M. D. Slow-binding human serine racemase inhibitors from high- throughput screening of combinatorial libraries. J. Med. Chem 2006, 49, 2388-2397.
[30] Mehrotra, M. M.; Heath, J. A.; Rose, J. W.; Smyth, M. S.; Seroogy, J.;
Volkots, D. L.; Ruhter, G.; Schotten, T.; Alaimo, L.; Park, G.; Pandey, A.;
Scarborough, R. M. Spirocyclic nonpeptide glycoprotein IIb-IIIa antagonists. Part 3: synthesis and SAR of potent and specific 2,8- diazaspiro[4.5]decanes. Bioorg. Med. Chem. Lett. 2002, 12 (7), 1103- 1107.
[31] DeVries, V. G.; Largis, E. E.; Miner, T. G.; Shepherd, R. G.; Upeslacis, J.
Potential antiatherosclerotic agents. 4. [(Functionalizedalkyl) amino]benzoic acid analogues of cetaben. J. Med. Chem. 1983, 26 (10), 1411-1421.
[32] Lu, Z.; Tweig, R. J. Copper-catalyzed aryl amination in aqueous media with 2-dimethylaminoethanol ligand. Tetrahedron Lett. 2005, 46 (17), 2997-3001.
[33] Zhang, X.; Dillen, L.; Vanhoutte, K.; Van Dongen, W.; Esmans, E.;
Claeys, M. Characterization of unstable intermediates and oxidized products formed during cyanogen bromide cleavage of peptides and proteins by electrospray mass spectrometry. Anal. Chem. 1996, 68, 3422- 3430.
[34] Yue, W.; Koen, Y. M.; Williams, T. D.; Hanzlik, R. P. Use of isotopic signatures for mass spectral detection of protein adduction by chemically reactive metabolites of bromobenzene: Studies with model proteins.
Chem. Res. Toxicol. 2005, 18, 1748-1754.
[35] Tornoe, C. W.; Sanderson, S. J.; Mottram, J. C.; Coombs, G. H.; Meldal, M. Combinatorial library of peptidotriazoles: identification of [1,2,3]- triazole inhibitors against a recombinant Leishmania mexicana cysteine protease. J. Comb. Chem. 2004, 6 (3), 312-324.
[36] Knaggs, A. R. The biosynthesis of shikimate metabolites. Nat. Prod. Rep.
2003, 20 (1), 119-136.
[37] Smith, D. A.; Parish, T.; Stoker, N. G.; Bancroft, G. J. Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates. Infect. Immun. 2001, 69 (2), 1142-1150.
[38] McArthur, J. D.; West, N. P.; Cole, J. N.; Jungnitz, H.; Guzman, C. A.;
Chin, J.; Lehrbach, P. R.; Djordjevic, S. P.; Walker, M. J. An aromatic amino acid auxotrophic mutant of Bordetella bronchiseptica is attenuated and immunogenic in a mouse model of infection. FEMS Microbiol. Lett.
2003, 221 (1), 7-16.
[39] Carniel, E. The Yersinia high-pathogenicity island: an iron-uptake island.
Microbes. Infect. 2001, 3 (7), 561-569.
[40] Budzikiewicz, H. Siderophores of the human pathogenic fluorescent pseudomonads. Curr. Top. Med. Chem. 2001, 1 (1), 1-6.
[41] Payne, R. J.; Toscano, M. D.; Bulloch, E. M.; Abell, A. D.; Abell, C.
Design and synthesis of aromatic inhibitors of anthranilate synthase. Org.
Biomol. Chem. 2005, 3 (12), 2271-2281.
[42] Kozlowski, M. C.; Tom, N. J.; Seto, C. T.; Sefler, A. M.; Bartlett, P. A.
Chorismate-utilizing enzymes isochorismate synthase, anthranilate synthase, and p-aminobenzoate synthase: mechanistic insight through inhibitor design. J. Am. Chem. Soc. 1995, 117 (8), 2128-2140.
[43] He, Z.; Stigers Lavoie, K. D.; Bartlett, P. A.; Toney, M. D. Conservation of mechanism in three chorismate-utilizing enzymes. J. Am. Chem. Soc.
2004, 126 (8), 2378-2385.
[44] Sudharsan Sridharan, Nigel Howard, Olivier Kerbarh,Michal Blaszczyk, Chris Abell and Tom L. Blundell, J. Mol. Biol. (2010) 397, 290–300.
[45] Gehring, A. M., Bradley, K. A. & Walsh, C. T., Enterobactin biosynthesis in Escherichia coli: isochorismate lyase (EntB) is a bifunctional enzyme that is phosphopantetheinylated by EntD and then acylated by EntE using ATP and 2,3-dihydroxybenzoate. Biochemistry (1997). 36, 8495–84503.
[46] Sakaitani, M., Rusnak, F., Quinn, N. R., Tu, C., Frigo, T. B., Berchtold, G. A. & Walsh, C. T. Mechanistic studies on trans-2,3-dihydro-2,3- dihydroxybenzoate dehydrogenase (Ent A) in the biosynthesis of the iron chelator enterobactin. Biochemistry (1990), 29, 6789–6798.
[47] Reichert, J., Sakaitani, M. & Walsh, C. T. Characterization of EntF as a serine-activating enzyme. Protein Sci (1992), 1, 549–556.
[48] Kolappan, S., Zwahlen, J., Zhou, R., Truglio, J. J., Tonge, P. J. & Kisker, C. Lysine 190 is the catalytic base in MenF, the menaquinone-specific Crystal Structure of Escherichia coli EntC 299 isochorismate synthase from Escherichia coli: implications for an enzyme family. Biochemistry (2007), 46, 946–953.
[49] Dahm, C., Muller, R., Schulte, G., Schmidt, K. & Leistner, E. The role of isochorismate hydroxymutase genes entC and menF in enterobactin and menaquinone biosynthesis in Escherichia coli. Biochim. Biophys. Acta (1998), 1425, 377–386.
[50] Buss, K., Muller, R., Dahm, C., Gaitatzis, N., Skrzypczak-Pietraszek, E., Lohmann, S. et al,. Clustering of isochorismate synthase genes menF and entC and channeling of isochorismate in Escherichia coli. Biochim.
Biophys. Acta (2001), 1522, 151–157.
[51] Knochel, T., Ivens, A., Hester, G., Gonzalez, A., Bauerle, R., Wilmanns, M. et al., The crystal structure of anthranilate synthase from Sulfolobus solfataricus: functional implications. Proc. Natl Acad. Sci. USA (1999), 96, 9479–9484.
[52] Kerbarh, O., Chirgadze, D. Y., Blundell, T. L. & Abell, C. Crystal structures of Yersinia enterocolitica salicylate synthase and its complex with the reaction products salicylate and pyruvate. J. Mol. Biol. (2006), 357, 524–534.
[53] Harrison, A. J., Yu, M., Gardenborg, T., Middleditch, M., Ramsay, R. J., Baker, E. N. & Lott, J. S. The structure of MbtI from Mycobacterium tuberculosis, the first enzyme in the biosynthesis of the siderophoremycobactin, reveals it to be a salicylate synthase. J. Bacteriol.
(2006) 188, 6081–6091.
[54] Parsons, J. F., Shi, K. M. & Ladner, J. E. Structure of isochorismate synthase in complex with magnesium. Acta Crystallogr. D(2008) 64, 607- 610.
[55] Parsons, J. F., Jensen, P. Y., Pachikara, A. S., Howard, A. J., Eisenstein, E. & Ladner, J. E. Structure of Escherichia coli aminodeoxychorismate synthase: architectural conservation and diversity in chorismate-utilizing enzymes. Biochemistry (2002) 41, 2198–2208.
[56] Kerbarh, O., Ciulli, A., Howard, N. I. & Abell, C. Salicylate biosynthesis:
overexpression, purification, and characterization of Irp9, a bifunctional salicylate synthase from Yersinia enterocolitica. J. Bacteriol. (2005), 187, 5061–5066.
[57] Kerbarh, O., Bulloch, E. M., Payne, R. J., Sahr, T., Rebeille, F. & Abell, C. Mechanistic and inhibition studies of chorismate-utilizing enzymes.
Biochem. (2005), Soc. Trans. 33, 763–766.
[58] DeClue, M. S., Baldridge, K. K., Kast, P. & Hilvert, D. Experimental and computational investigation of the uncatalyzed rearrangement and elimination reactions of isochorismate. J. Am. Chem. Soc. (2006), 128, 2043–2051.
[59] Zamir, L. O., Nikolakakis, A., Bonner, C. A. & Jensen, R. A. Evidence for enzymatic formation of isoprephenate from isochorismate. Bioorg. Med.
Chem. Lett. (1993), 3, 1441–1446.
[60] Kristin T. Ziebart and Michael D. Toney, Biochemistry 2010, 49, 2851–
2859 2851.
[61] Mavrodi, D. V., Ksenzenko, V. N., Bonsall, R. F., Cook, R. J., Boronin, A. M., and Thomashow, L. S. A seven-gene locus for synthesis of phenazine-1-carboxylic acid by Pseudomonas fluorescens 2-79. J.
Bacteriol. (1998) 180, 2541–2548.
[62] He, Z., and Toney, M. D. Direct detection and kinetic analysis of covalent intermediate formation in the 4-amino-4-deoxychorismate synthase catalyzed reaction. Biochemistry (2006) 45, 5019–5028.
[63] Raushel, F. M., Thoden, J. B., and Holden, H. M. (2003) Enzymes with molecular tunnels. Acc. Chem. Res. 36, 539–548.
[64] Huang, X. Y., Holden, H. M., and Raushel, F. M. Channeling of substrates and intermediates in enzyme-catalyzed reactions. Annu. Rev. Biochem.
(2001) 70, 149–180.
[65] Kerbarh, O., Ciulli, A., Chirgadze, D. Y., Blundell, T. L., and Abell, C.
Nucleophile selectivity of chorismate-utilizing enzymes. ChemBioChem (2007) 8, 622–624.
[66] Liu, J., Quinn, N., Berchtold, G. A., and Walsh, C. T. Overexpression, purification, and characterization of isochorismate synthase (EntC), the first enzyme involved in the biosynthesis of enterobactin from chorismate.
Biochemistry (1990) 29, 1417–1425.
[67] Zwahlen, J., Kolappan, S., Zhou, R., Kisker, C., and Tonge, P. J. Structure and mechanism of MbtI, the salicylate synthase from Mycobacterium tuberculosis. Biochemistry (2007) 46, 954–964.
[68] Afonnikov, D.A., Oshchepkov, D. Yu., and Kolchanov, N. A.
Detection of conserved physico-chemical characteristics of proteins by analyzing clusters of position with co-ordinated substitutions.
Bioinformatics (2001) 17 (11), 1035-1046.
[69] Morollo, A. A., and Bauerle, R. Characterization of composite aminodeoxyisochorismate synthase and aminodeoxyisochorismate lyase activities of anthranilate synthase. Proc. Natl. Acad. Sci. (1993) U.S.A.
90, 9983–9987.
[70] Gouet, P., Courcelle, E., Stuart, D. I. & Metoz, F. ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics (1999), 15, 305–308.
